NogoA, a player in neurodegenerative diseases? Characterization of human iPSC-derived NogoA knockout midbrain neurons

Weber, Michaela Bettina Maria (2023). NogoA, a player in neurodegenerative diseases? Characterization of human iPSC-derived NogoA knockout midbrain neurons (Submitted). (Dissertation, Veterinary Pharmacology and Toxicology, Vetsuisse)

[img] Text
Weber_M_2023_Diss_EN.pdf - Submitted Version
Restricted to registered users only
Available under License BORIS Standard License.

Download (2MB) | Request a copy

Parkinson's disease (PD) was reported to be the fastest growing neurological disorder worldwide. The histopathological characteristics of PD are a loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The neurite growth inhibitor A (NogoA) was found to co-localize with dopaminergic neurons in the SNpc of the brain. Antagonization of NogoA was shown to increase survival of transplanted human dopaminergic neurons in a PD rat model, suggesting a role of NogoA in PD.
CRISPR/Cas9 technology was used to knockout (KO) the reticulon 4 (RTN4) gene encoding for NogoA. A monoclonal RTN4-KO induced pluripotent stem cell line was successfully generated and differentiated into mature midbrain neurons with a dopaminergic phenotype. The RTN4-KO cell line as well as wild type and mock-transfected control cells were analyzed by immunofluorescence imaging and Western blotting. Markers of neuronal development and synaptic plasticity were not significantly altered between all groups. A visual increase but no significant change of the astrocyte marker S100β was found in the RTN4-KO cells. Furthermore, the RTN4-KO clone showed a significant reduction of α-synuclein and a visual tendency of more dopaminergic neurons. In future studies, the RTN4-KO clone will be used in midbrain organoid models of PD to study the role of NogoA in the pathogenesis and therapy of PD.

Item Type:

Thesis (Dissertation)

Division/Institute:

05 Veterinary Medicine > Department of Clinical Research and Veterinary Public Health (DCR-VPH) > Veterinary Pharmacology and Toxicology
05 Veterinary Medicine > Department of Clinical Research and Veterinary Public Health (DCR-VPH)

UniBE Contributor:

Weber, Michaela Bettina Maria

Subjects:

600 Technology > 630 Agriculture
500 Science > 570 Life sciences; biology

Funders:

[4] Swiss National Science Foundation ; [239] UniBern Forschungsstiftung

Language:

English

Submitter:

Angélique Ducray

Date Deposited:

08 Aug 2023 11:24

Last Modified:

08 Aug 2023 11:24

Uncontrolled Keywords:

NogoA, CRISPR/Cas9, human iPSC-derived midbrain neurons, Parkinson’s disease

BORIS DOI:

10.48350/185281

URI:

https://boris.unibe.ch/id/eprint/185281

Actions (login required)

Edit item Edit item
Provide Feedback